Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current developments in peanut allergy.

Kricia Palmer1, Wesley Burks

  • 1Duke University Medical Center, Pediatric Allergy and Immunology, Durham, New Carolina 27710, USA.

Current Opinion in Allergy and Clinical Immunology
|May 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When Protocol Meets Reality.

JAMA·2026
Same author

WALKING BACKWARDS: REFLECTING ON THE VALUE OF MENTORS.

Transactions of the American Clinical and Climatological Association·2024
Same author

Reply.

The Journal of allergy and clinical immunology·2022
Same author

Preliminary Development of the Food Allergy Coping and Emotions Questionnaires for Children, Adolescents, and Young People: Qualitative Analysis of Data on IgE-Mediated Food Allergy from Five Countries.

The journal of allergy and clinical immunology. In practice·2018
Same author

Erratum to: Allergen immunotherapy for IgE-mediated food allergy: protocol for a systematic review.

Clinical and translational allergy·2017
Same author

The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming.

The World Allergy Organization journal·2017
Same journal

Biosimilars in allergology: an outline in pediatric patients.

Current opinion in allergy and clinical immunology·2026
Same journal

The immunogenetic landscape of systemic lupus erythematosus.

Current opinion in allergy and clinical immunology·2026
Same journal

Circadian control of innate immunity: molecular mechanisms and implications for allergic disorders.

Current opinion in allergy and clinical immunology·2026
Same journal

Probiotics in allergic disease: from adjunct supplement to immune-modifying strategy (2026 update).

Current opinion in allergy and clinical immunology·2026
Same journal

Updates on drug-induced anaphylaxis in children.

Current opinion in allergy and clinical immunology·2026
Same journal

Beta-lactam de-labelling as a core antimicrobial stewardship strategy in the era of the antimicrobial resistance pandemic: a narrative review.

Current opinion in allergy and clinical immunology·2026
See all related articles

Recent advances in peanut allergy research reveal complex immune responses and novel treatments. Understanding peanut allergens and immune pathways may lead to better prediction, prevention, and treatment of this serious food sensitivity.

Area of Science:

  • Immunology
  • Allergology
  • Food Science

Background:

  • Peanut allergy is a prevalent and severe food sensitivity, with increasing incidence in children.
  • The immunological mechanisms underlying peanut allergy are complex, involving T-helper cell responses and regulatory pathways.

Purpose of the Study:

  • To review recent advancements in the understanding of peanut allergy immunology.
  • To highlight novel and emerging treatment strategies for peanut allergy.

Main Methods:

  • Review of current literature on peanut allergy immunology.
  • Analysis of studies on peanut allergen characterization and immune response.
  • Examination of ongoing clinical investigations into new therapeutic approaches.

Related Experiment Videos

Main Results:

  • Peanut sensitization involves both Th1 and Th2 immune responses, with cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) potentially modulating response intensity.
  • The food matrix influences immune responses to peanut; purified allergens may have limited intrinsic stimulatory capacity.
  • Ara h 1 and Ara h 2 are potent peanut allergens, while Ara h 3's allergenicity may be underestimated.
  • Diverse IgE-binding patterns correlate with clinical symptom severity.
  • Novel treatments under investigation include traditional Chinese medicine, modified immunotherapy, and adjuvant-enhanced immunotherapy.

Conclusions:

  • Understanding the immunologic response and key peanut allergens can aid in predicting severe reactions.
  • Insights into peanut allergy mechanisms may facilitate the prevention of sensitization.
  • Advanced knowledge supports the development of effective treatments for individuals with peanut allergy.